Rick Lindberg, PhD

Dr. Rick Lindberg, until 2017, was Executive Director and Head of the Centers for Therapeutic Innovation – California (CTI-California) at Pfizer. As the Head of CTI-California, Rick was responsible for research sites in San Francisco and San Diego that worked with west coast and Australian universities in intimate and innovative collaborations. He led an effort […]

Tom Boone, MS

Tom Boone has more than 34 years of accomplishments in the discovery and development of protein therapeutics. Tom worked at Amgen for 28 years and served in positions of increasing responsibility in growing Amgen Protein Sciences to an organization of over 300 researchers across five different sites while maintaining a long tradition of industry excellence. […]

Bill Murray, PhD

Bill Murray received his Ph.D. in Chemical Biology at the State University of New York at Stony Brook. After a Post Doctoral Fellowship in Chemistry at MIT, he joined Johnson and Johnson in 1980 as a synthetic organic chemist. He has spent most of his career in drug discovery and development chemistry. During his career […]

Cindy Ru, PhD

​Previous experience: CSO of CARsgen Therapeutics Clinical development leadership roles in Novartis, Pfizer and Exelixis

Wendy Levin, MD

Previous experience: Vice President of Clinical Development, Fate Therapeutics Vice President of Clinical Development and Medical Affairs, MEI Pharma Inc Director of Clinical Oncology, Pfizer